Mallia Aesthetics, pioneer of cosmetic innovations, will present her innovative approach to hair growth based on SCD83 during the 24th International Symposium on Happening Science (Hairs’25). As a Gold sponsor, Mallia strengthens its influence at the crossroads of scientific research and cosmetic development.
Professor Alexander Steinkasserer, co -founder of Mallia, will present new discoveries on the potential of SCD83 in the fight against hair loss. Research indicates that SCD83 creates an anti-inflammatory environment in the hair follicles, prevents cell death and activates stem cells, thus promoting growth and thickness of the hair. Recently patented in Europe, the SCD83 has therapeutic perspectives in dermatology and healing of wounds.
The first commercial product based on SCD83 in Mallia should be marketed by the end of 2025, highlighting the company’s strategic advances in terms of innovative cosmetic solutions.
R. P.
